Ocular Therapeutix
OCUL
OCUL
68 hedge funds and large institutions have $147M invested in Ocular Therapeutix in 2018 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 27 increasing their positions, 12 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
5% more capital invested
Capital invested by funds: $140M → $147M (+$6.75M)
0.75% more ownership
Funds ownership: 57.79% → 58.55% (+0.75%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
68
Holding in Top 10
3
Calls
$1.32M
Puts
$364K
Top Buyers
| 1 | +$1.82M | |
| 2 | +$1.18M | |
| 3 | +$470K | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$426K |
| 5 |
State Street
Boston,
Massachusetts
|
+$399K |
Top Sellers
| 1 | -$2.43M | |
| 2 | -$1.43M | |
| 3 | -$359K | |
| 4 |
Millennium Management
New York
|
-$276K |
| 5 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$241K |